Covifor Current Affairs - 2020

Mylan gets DCGI Approval to launch its Generic Version of Remdesivir ‘DESREM’ at Rs 4800

Global pharmaceutical company Mylan N.V was given approval by the Drug Controller General of India (DCGI) for the launch of its generic version of Gilead Sciences Remdesivir drug for the treatment of COVID-19 positive patients in India. Mylan N.V is currently the second-largest company in the world for the manufacturing of generic and specialty pharmaceuticals. Read More…

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic Read More…